Free Newsletter
Six die after Chinese antibody injections
Just as the heparin hoopla was starting to settle down, now China is reporting that six patients in Jiangxi province have died after injections of immunoglobulins. All the injections came from a single batch made by Jiangxi Yabo Bio-Pharmaceutical, which has been ordered to stop producing the drug. China's State Food and Drug Administration has launched an investigation. Penalties for pharma-tampering are severe in China; last month, five officials of a company that sold a tainted antibiotic were sentenced to seven years in prison.
- read the AFP story
- check out the Associated Press article
Related Articles:
U.S., China trade blame on heparin
China launches drug recall system
China to overhaul drug safety regulations
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment